MediView logo
  • Home
  • Technology
        • About Our TechDiscover our technology and how it works.
        • OmnifyXR®Customize workflow visualization, unlock greater potential of imaging, and facilitate enhanced ergonomics for procedures.
        • MediView XR90Experience unprecedented 3D views of patient internal anatomy to plan and execute procedures with increased confidence.
  • About
        • About UsWe’re on a mission to advance healthcare delivery with intuitive visualization.
        • TeamMeet the great minds who are transforming diagnostic imaging, surgical navigation, and patient care.
        • Visionary EducationDiscover AR solutions to enhance learning and improve student outcomes.
        • CareersJoin us as we drive our vision forwards and learn more about open opportunities at MediView.
  • In The News
  • Publications
  • Contact
Contact
First in Human

First in Human

World’s first-in-human augmented reality tumor ablation completed at the Cleveland Clinic.

MediView XR, LLC, today announced the successful first-in-human use of its intraoperative Real-Time, Fused Holographic Visualization (RTFHV) Extended Reality Surgical Navigation Platform for a liver tumor ablation procedure. MediView is an Ohio-based medical device startup company focused on launching a stand-alone Extended Reality Surgical Navigation Platform to accurately target, navigate, biopsy and ablate cancerous lesions.

“To the best of our knowledge, this is the first time globally that extended reality surgical navigation has been evaluated intraoperatively in a human liver tumor ablation procedure, which is a significant milestone in the realm of extended reality guided surgery.” said Karl West, M.S., Inventor of the Technology and Director of Medical Device Solutions at Cleveland Clinic’s Lerner Research Institute.

The Extended Reality assisted liver tumor ablation procedure was completed by Dr. Charles Martin III, M.D., Director of Interventional Oncology at the Cleveland Clinic, as part of the safety and feasibility trial for the technology (Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation – clinicaltrials.gov).

“MediView’s RTFHV Extended Reality surgical navigation system achieved proof-of-concept in a highly complex soft-tissue percutaneous liver tumor ablation procedure,” said Dr. Martin. “This revolutionary medical imaging technology has the potential to redefine the cancer care continuum.”

Unlike standard procedural images that are displayed on a conventional 2D display screen, MediView’s RTFHV system projects 3D holograms of patient-specific internal anatomy in real-time onto the patient during the procedure.  Each patient’s personal images are aligned with their anatomical structures through a proprietary registration process.

MediView’s technology is designed to permit surgeons to look directly at a patient, see beneath their skin, and peer into their internal anatomy during a procedure.  Before the procedure the precise path of the biopsy needle and probe to treat the cancer can be plotted out. During the procedure the physician then uses the head mounted display to see the patient’s internal anatomical structures with the plotted trajectory of their surgical tools.  Throughout the procedure the surgical tools are tracked to the targeted anatomy with mini-GPS-like navigation.

“The potential benefits of extended reality assisted surgical procedures are tremendous.  Existing surgical imaging modalities have limitations that reduce their effectiveness in percutaneous procedures and expose medical professionals to risks associated with radiation exposure, which MediView’s technology is specifically designed to overcome” said John W. Black, CEO and Co-Founder of MediView. “We are excited to partner with the lab at Cleveland Clinic’s Lerner Research Institute to design, test and refine this technology.”

 

Related posts:

adam rakestraw on x ray vision newsMovers & Shakers: Adam Rakestraw on X-ray vision, building his own house and pivoting from law to medical tech MediView Recognized In The Medical Capital Innovation Competition MediView TechnologyMediView XR, Inc. Secures $15M Strategic Funding Round with Backing from Leading Collaborators across Clinical, Industry and Government dr tasse portraitMediview Announces New Clinical Advisory Board Member (Jordan Tasse)

Related posts:

HoloLens To Assess The Resectability Of Ovarian Cancer

MediView XR Receives Investment from JobsOhio Growth Capital Fund

Medivew, Transformational Augmented Reality Medtech Company, Secures $9.9 Million Safe Funding

Mediview Announces New Advisory Board Member (Mark)

MediView Receives FDA 510(k) Clearance for XR90 Augmented Reality-Based Visualization and Navigation Platform

Browse Topics

  • News
216-306-1977
info@mediview.com

Technology

  • About Our Tech
  • OmnifyXR
  • Mediview XR90

About

  • Careers
  • Visionary Education
  • Team
  • About Us

Insights

  • In The News
  • Publications

© 2025 MediView XR, Inc. All Rights Reserved.

Privacy Policy | Terms of Service